drug

(redirected from orphan drug)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

drug

noun alterant, analgesic, anesthetic, anesthetic agent, anodyne, antibiotic, chemical substance, curative preparation, medical preparation, medicament, medication, medicinal component, medicinal innredient, narcotic preparation, narcotic substance, opiate, painkiller, palliative, physic, prescription, remedy, sedative, soporific, stimulant, stupefacient
Associated concepts: adulterated drugs, dangerous drugs, drug addiction, habit-forming drug, influence of drugs, laaeling of drugs, poisonous drugs or chemicals, possession of drugs, preparation of drugs, prescription drugs, regulaaion of drugs, sale of drugs

drug

verb administer, anesthetize, anoint, apply a remedy, benumb, cure, deaden, desensitize, dose, dull, heal, inject, medicare, medicate, narcotize, numb, palliate, physic, poultice, prescribe, put to sleep, stun, stupefy, treat
Associated concepts: drug addicts
References in periodicals archive ?
Reportedly, the US Congress had passed the Orphan Drug Act in 1983 to provide incentives for industry investment in treatments for rare conditions.
Since 2007, the increase in orphan drug spending has a direct link to the rising number of orphan drugs that have since been approved by the Food and Drug Administration, according to Divino.
The Orphan Drug Act (the Act) provides procedures to encourage and facilitate the development of drugs for rare diseases or conditions namely those that affect fewer than 200,000 persons in the U.
Manage expectations: Sales forecasts for the orphan drug market at the product, therapy area, molecule type, & peer set level for the period 2011-17.
According to the company, the Orphan Drug Designation is an important milestone for it and it recognises the promise of WTX101 as a potential new treatment for ALS.
The product has received orphan drug designation for four indications: the treatment of invasive candidiasis, invasive aspergillosis, coccidioidomycosis, and rare mold infections caused by Scedosporium spp, Fusarium spp, and Mucorales fungi.
We wanted to determine whether the FDA requires that orphan drug applications provide the conventional effectiveness data that are ordinarily expected for most drugs for more prevalent diseases or whether the agency has over the years exercised flexibility in approving drugs for patients with rare diseases.
Orphan Drug designation in the European Union provides a 10-year period of post-approval marketing exclusivity and other financial incentives for new drugs that offer significant therapeutic advantage over other approved treatments of rare conditions (conditions affecting no more than 5 in 10,000 persons).
The orphan drug and balloon technologies discussed here illustrate the significant impact that very expensive, very low volume technologies and high volume, "cost saving" technologies might have on an individual plan.
BioGaia (STO:BIOGB) announced on Monday that its subsidiary Infant Bacterial Therapeutics (IBT) has obtained the Orphan Drug Designation for the prevention of necrotising enterocolitis (NEC) in Europe.
But companies that produce them under the orphan drug designation are offered several advantages, including research grants, tax benefits, protocol assistance, marketing exclusivity (seven years in the United States) and regulatory challenges (such as a smaller number of clinical trials) that are less daunting than those faced by other new medicines.
Our MPS-VI program builds on BioMarin's expertise in the development of enzyme replacement therapies, and positions us now with two orphan drug products in human clinical trials.